Multiple Sclerosis - Epidemiology Forecast to 2023

  • ID: 4300707
  • Report
  • 40 pages
  • DelveInsight
UP TO OFF
until Dec 31st 2018
1 of 3
“Multiple Sclerosis - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Multiple Sclerosis in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Multiple Sclerosis prevalent or incident cases segmented by age, sex and subpopulations. The Report also discusses the prevailing risk factors, disease burden with special emphasis on the unmet medical need associated with the Multiple Sclerosis . The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by our team of industry experts.

Please Note: This report requires 5-7 business days to complete. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.

Scope of the Report:
- The Report includes the prevalent population and how will it change over the next eight years.
- Prevalent or incident cases segmented by age and sex.
- Coverage of key Multiple Sclerosis subpopulations and its prevalent or incident cases
- The key differences in epidemiology patterns across the seven market segments

Key Coverage and Benefits:
- The report will help in developing business strategies by understanding the trends shaping and driving the global Multiple Sclerosis market.
- Identifying prevalent patient populations as well as risk factors in the global Multiple Sclerosis market will help to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the best opportunities for Multiple Sclerosis therapeutics in each of the markets covered.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Report Introduction
2. Snapshot of Total Prevalent or Incident cases by 7 MM
3. Executive Summary
Key Findings
4. Multiple Sclerosis Overview
Multiple Sclerosis Definition
Pathophysiology
Symptoms
Etiology
5. Risk Factors Associated with Multiple Sclerosis
6. Disease Burden & Unmet Need in the Market
7. Epidemiology and Patient Populations
Key Findings
Key Sources used and Forecast Methodology
Prevalent Cases and Incident Cases-2013-2023
Prevalent & Incident Cases by Category-2013-2023
- Age-Specific Prevalent/ Incident Cases of Multiple Sclerosis
- Sex-Specific Prevalent/Incident Cases of Multiple Sclerosis
- Disease Type Specific Prevalent/Incident Cases of Multiple Sclerosis
Prevalent & Incident Cases by 7 MM-2013-2023
- Multiple Sclerosis Epidemiology of United States-2023
- Multiple Sclerosis Epidemiology of United Kingdom-2023
- Multiple Sclerosis Epidemiology of Germany-2023
- Multiple Sclerosis Epidemiology of France-2023
- Multiple Sclerosis Epidemiology of Spain-2023
- Multiple Sclerosis Epidemiology of Italy-2023
- Multiple Sclerosis Epidemiology of Japan-2023
8. Key Takeaways
9. Appendix
10. Report Methodology
11. Consulting Services
12. Disclaimer
13. About Us

List of Tables
Table 1: Clinical subtypes of Indication
Table 2: Risk Factors
Table 3: Prevalence cases (%) Region wise
Table 4: Sources used for forecasting the data
Table 5: Multiple Sclerosis Global Epidemiology, (2013-2023)
Table 6: Prevalent Cases of Multiple Sclerosis (Ages = XX Years), US (2013-2023)
Table 7: Prevalent Cases of Multiple Sclerosis By Sex (Males & Females), US (2013-2023)
Table 8: Prevalent Cases By Multiple Sclerosis Sub-population, US (2013-2023)
Table 9: Prevalent Cases of Multiple Sclerosis (Ages = XX Years), United Kingdom (2013-2023)
Table 10: Prevalent Cases of Multiple Sclerosis By Sex (Males & Females), United Kingdom (2013-2023)
Table 11: Prevalent Cases By Multiple Sclerosis Sub-population, United Kingdom (2013-2023)
Table 12: Prevalent Cases of Multiple Sclerosis (Ages = XX Years), Germany (2013-2023)
Table 13: Prevalent Cases of Multiple Sclerosis By Sex (Males & Females), Germany (2013-2023)
Table 14: Prevalent Cases By Multiple Sclerosis Sub-population, Germany (2013-2023)
Table 15: Prevalent Cases of Multiple Sclerosis (Ages = XX Years), France (2013-2023)
Table 16: Prevalent Cases of Multiple Sclerosis By Sex (Males & Females), France (2013-2023)
Table 17: Prevalent Cases By Multiple Sclerosis Sub-population, France (2013-2023)
Table 18: Prevalent Cases of Multiple Sclerosis (Ages = XX Years), Italy (2013-2023)
Table 19: Prevalent Cases of Multiple Sclerosis By Sex (Males & Females), Italy (2013-2023)
Table 20: Prevalent Cases By Multiple Sclerosis Sub-population, Italy (2013-2023)
Table 21: Prevalent Cases of Multiple Sclerosis (Ages = XX Years), Spain (2013-2023)
Table 22: Prevalent Cases of Multiple Sclerosis By Sex (Males & Females), Spain (2013-2023)
Table 23: Prevalent Cases By Multiple Sclerosis Sub-population, Spain (2013-2023)
Table 24: Prevalent Cases of Multiple Sclerosis (Ages = XX Years), Japan (2013-2023)
Table 25: Prevalent Cases of Multiple Sclerosis By Sex (Males & Females), Japan (2013-2023)
Table 26: Prevalent Cases By Multiple Sclerosis Sub-population, Japan (2013-2023)

List of Figures
Figure 1: Prevalence cases (%) Region wise
Figure 2: Sources used for forecasting the data
Figure 3: Multiple Sclerosis Global Epidemiology, (2013-2023)
Figure 4: Prevalent Cases of Multiple Sclerosis (Ages = XX Years), US (2013-2023)
Figure 5: Prevalent Cases of Multiple Sclerosis By Sex (Males & Females), US (2013-2023)
Figure 6: Prevalent Cases By Multiple Sclerosis Sub-population,US (2013-2023)
Figure 7: Prevalent Cases of Multiple Sclerosis (Ages = XX Years), United Kingdom (2013-2023)
Figure 8: Prevalent Cases of Multiple Sclerosis By Sex (Males & Females), United Kingdom (2013-2023)
Figure 9: Prevalent Cases By Multiple Sclerosis Sub-population,United Kingdom (2013-2023)
Figure 10: Prevalent Cases of Multiple Sclerosis (Ages = XX Years), Germany (2013-2023)
Figure 11: Prevalent Cases of Multiple Sclerosis By Sex (Males & Females), Germany (2013-2023)
Figure 12: Prevalent Cases By Multiple Sclerosis Sub-population,Germany (2013-2023)
Figure 13: Prevalent Cases of Multiple Sclerosis (Ages = XX Years), France (2013-2023)
Figure 14: Prevalent Cases of Multiple Sclerosis By Sex (Males & Females), France (2013-2023)
Figure 15: Prevalent Cases By Multiple Sclerosis Sub-population,France (2013-2023)
Figure 16: Prevalent Cases of Multiple Sclerosis (Ages = XX Years), Italy (2013-2023)
Figure 17: Prevalent Cases of Multiple Sclerosis By Sex (Males & Females), Italy (2013-2023)
Figure 18: Prevalent Cases By Multiple Sclerosis Sub-population,Italy (2013-2023)
Figure 19: Prevalent Cases of Multiple Sclerosis (Ages = XX Years), Spain (2013-2023)
Figure 20: Prevalent Cases of Multiple Sclerosis By Sex (Males & Females), Spain (2013-2023)
Figure 21: Prevalent Cases By Multiple Sclerosis Sub-population,Spain (2013-2023)
Figure 22: Prevalent Cases of Multiple Sclerosis (Ages = XX Years), Japan (2013-2023)
Figure 23: Prevalent Cases of Multiple Sclerosis By Sex (Males & Females), Japan (2013-2023)
Figure 24: Prevalent Cases By Multiple Sclerosis Sub-population,Japan (2013-2023)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll